Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study).
Joaquin Saez-PeñataroFerran TorresJoan BartraJuan BascuasAnna VilellaMarta TortajadaSebastiana QuesadaElisenda GonzálezEster López-SuñéAntoni CastellsSandra SerranoConcepción CamachoAntoni TrillaGonzalo Calvonull nullPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2022)
Our study shows that mRNA-1273 had greater reactogenicity than BNT162b2. Overall, both vaccines had an adequate tolerability profile. mRNA-1273 vaccination caused fewer ARs with milder severity in SOTRs.